TENT4A — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL21327154	1.00	1/20
SCHEMBL21327157	1.00	1/20
SCHEMBL21327150	0.88	1/20
SCHEMBL21327138	0.84	1/20
SCHEMBL21327140	0.84	1/20
SCHEMBL21327202	0.80	1/20
SCHEMBL19953243	0.77	1/20
SCHEMBL20876569	0.77	1/20
SCHEMBL16929853	0.73	1/20
SCHEMBL16942404	0.73	1/20
SCHEMBL16942409	0.73	1/20
SCHEMBL19924549	0.73	1/20
SCHEMBL21043364	0.73	1/20
SCHEMBL21327114	0.72	1/20
SCHEMBL21327116	0.72	1/20
SCHEMBL16930014	0.71	1/20
SCHEMBL21043355	0.71	1/20
SCHEMBL21327146	0.70	1/20
SCHEMBL21327205	0.70	1/20
SCHEMBL16929914	0.70	1/20

Clinical trials — most relevant to TENT4A by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Tumor Gene Expression in Women With Ovarian Cancer	PHASE4	COMPLETED
A Phase II Study of TX Regimen as First-line Treatment for Asian Elderly Patients With Advanced Adenocarcinoma of Lung	PHASE2	COMPLETED
Genetic Investigation of Solid Tumors Cohort	nan	COMPLETED
Genetic Investigation of Cancer Predisposition	nan	NOT_YET_RECRUITING
Exome Analysis in Hearing Impaired Patients	nan	UNKNOWN
Serum Betatrophin Levels and Its Influencing Factors in Patients With Hyperthyroidism	nan	UNKNOWN
Role of Nitric Oxide in Diabetic Patients With Erectile Dysfunction	nan	COMPLETED
The Association Between Post-ERCP Acute Pancreatitis and Various Genetic Mutations	nan	COMPLETED
Muscle Tissue Bank for Muscular Dystrophy	nan	COMPLETED
Genetic Analysis of Thyrotoxic Periodic Paralysis	nan	COMPLETED
CoMPaSS-NMD - Computational Models for New Patients Stratification Strategies of HNMD	nan	ENROLLING_BY_INVITATION
Epigenetics, DNA Methylation Patterns and Periodontal Disease	nan	COMPLETED
Thermogenic Silencer Regulatory Factors in Humans	nan	ACTIVE_NOT_RECRUITING
Characteristics of Idiopathic Familial Voice Disorders	nan	COMPLETED
Assessment Of Long Noncoding RNA CCAT1 In Colorectal Cancer Patients	nan	UNKNOWN
Diagnosis of Graft Pathology by TruGraf	nan	RECRUITING
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve	nan	UNKNOWN
Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts	nan	COMPLETED
Study of Constitutional Platelet Disease	nan	UNKNOWN
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients	nan	RECRUITING
Biology of Thymic Tumors	nan	COMPLETED
Genetic Characterization of Parkinson's Disease	nan	COMPLETED
Human Epididymis Protein 4 in Endometrial Carcinoma	nan	COMPLETED
Identification of a New Gene Involved in Hereditary Lipodystrophy	nan	COMPLETED
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH)	nan	COMPLETED
Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus	nan	ACTIVE_NOT_RECRUITING
Telomeres Length in Israeli Fibrotic ILD Patients	nan	ENROLLING_BY_INVITATION
Identification of New Genes Implicated in Rare Neurosensory Diseases by Whole Exome Sequencing	nan	UNKNOWN
Long-read Genome Sequencing for the Molecular Diagnosis of Dystonia	nan	RECRUITING
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy	nan	UNKNOWN

Related proteins — ESM-2 sequence neighbours (a TENT4A binder may also engage these)

Protein	Name	Similarity
Q6PB75	—	0.999	Q6PB75 →
Q8AXV5	—	0.987	Q8AXV5 →
Q63099	—	0.987	Q63099 →
NR4A1	Nuclear receptor subfamily 4immunitygroup A member 1	0.987	landscape →
P50241	—	0.987	P50241 →
P16058	—	0.986	P16058 →
E1BE02	—	0.986	E1BE02 →
Q2YDU3	—	0.986	Q2YDU3 →
Q01956	—	0.986	Q01956 →
MIDEAS	Mitotic deacetylase-associated SANT domain protein	0.985	landscape →
Q4ZHA6	—	0.985	Q4ZHA6 →
Q9C0B9	—	0.985	Q9C0B9 →
Q7YR49	—	0.984	Q7YR49 →
Q5RIX9	—	0.984	Q5RIX9 →
Q640H3	—	0.984	Q640H3 →
Q80XS6	—	0.984	Q80XS6 →
Q8VHQ2	—	0.984	Q8VHQ2 →
Q0IHB0	—	0.984	Q0IHB0 →
Q8K3T3	—	0.984	Q8K3T3 →
Q9H8N7	—	0.984	Q9H8N7 →
Q9YH33	—	0.984	Q9YH33 →
P22829	—	0.984	P22829 →
Q62318	—	0.984	Q62318 →
Q61501	—	0.984	Q61501 →
Q9H694	—	0.984	Q9H694 →
Q8AXV6	—	0.984	Q8AXV6 →
Q9H329	—	0.984	Q9H329 →
O70405	—	0.984	O70405 →
Q7TN02	—	0.984	Q7TN02 →
Q7ZX21	—	0.984	Q7ZX21 →